Insider · CIK 0001477733
Slager David Mark
Reports to the SEC for 2 companies · NEW YORK, NY
Transactions
7
Companies
2
Filings
5
CIK
0001477733
Forms 4 and 5
Insider transactions
| Date | Company | Value |
|---|---|---|
| 2019-04-15 | ORMPORAMED PHARMACEUTICALS INC. · Stock Option (right to buy)A Award | — |
| 2017-10-31 | ORMPORAMED PHARMACEUTICALS INC.M Exercise/Conversion | +$63.6K |
| 2017-10-31 | ORMPORAMED PHARMACEUTICALS INC. · Warrant (right to buy)M Exercise/Conversion | −$19.9K |
| 2017-08-17 | ORMPORAMED PHARMACEUTICALS INC.M Exercise/Conversion | +$424K |
| 2017-08-17 | ORMPORAMED PHARMACEUTICALS INC. · Warrant (right to buy)M Exercise/Conversion | −$133K |
| 2017-06-30 | ORMPORAMED PHARMACEUTICALS INC. · Stock Option (right to buy)A Award | — |
| 2017-02-09 | ORMPORAMED PHARMACEUTICALS INC. · Stock Option (right to buy)A Award | — |
Recent filings
- 4Slager David Mark0001213900-19-006513SEC(opens sec.gov)
- 4Slager David Mark0001213900-17-011195SEC(opens sec.gov)
- 4Slager David Mark0001213900-17-008982SEC(opens sec.gov)
- 4ORAMED PHARMACEUTICALS INC.0001213900-17-007166SEC(opens sec.gov)
- 4ORAMED PHARMACEUTICALS INC.0001213900-17-001492SEC(opens sec.gov)
Companies
Address
767 FIFTH AVENUE 12TH FLOOR
NEW YORK, NY, 10153